What is Aardvark Therapeutics, Inc. Common Stock's Market Cap?

Aardvark Therapeutics, Inc. Common Stock's Market Cap is $30.4M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Enterprise Value?

Aardvark Therapeutics, Inc. Common Stock's Enterprise Value is -$43.5M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA?

Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA is 0.6×, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM) is -$69.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's EBITDA?

Aardvark Therapeutics, Inc. Common Stock's EBITDA is -$73.9M, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.19, based on as-reported figures from SEC (XBRL) filings.

What is Aardvark Therapeutics, Inc. Common Stock's Net Debt?

Aardvark Therapeutics, Inc. Common Stock's Net Debt is -$73.9M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Aardvark Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01223DLC1

1.39▼ 2.56 (-64.81%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 3.95
Day's Range: 1.39 – 3.00
52-Week Range: 1.39 – 16.61
Volume: 15.9M
Avg Volume: 639.6K

Share Statistics

Shares Outstanding
Employees: 40
Exchange: XNAS
Listed: 2025-02-13

Share count as of July 31, 2026

Aardvark Therapeutics, Inc. Common Stock (AARD) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Aardvark Therapeutics, Inc. Common Stock (AARD)

What is Aardvark Therapeutics, Inc. Common Stock's Market Cap?: Aardvark Therapeutics, Inc. Common Stock's Market Cap is $30.4M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Enterprise Value?: Aardvark Therapeutics, Inc. Common Stock's Enterprise Value is -$43.5M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA?: Aardvark Therapeutics, Inc. Common Stock's EV / EBITDA is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Net Income (TTM) is -$69.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's EBITDA?: Aardvark Therapeutics, Inc. Common Stock's EBITDA is -$73.9M, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Aardvark Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.19, based on as-reported figures from SEC (XBRL) filings.
What is Aardvark Therapeutics, Inc. Common Stock's Net Debt?: Aardvark Therapeutics, Inc. Common Stock's Net Debt is -$73.9M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AARDAs-filed SEC (XBRL) data